Carvedilol Tablet, Film Coated
Product Images NDC 68071-2773

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68071-2773). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 2773 6)

Pdp (68071 2773 6)
Label for Carvedilol 25 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a bottle containing 60 tablets. Each circular white tablet is engraved with 'G41' on one side and '25' on the other. It includes storage instructions and warnings to keep out of reach of children.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line graph comparing percent mortality over time in months between Carvedilol and placebo groups. The X-axis represents months from 0 to 21, and the Y-axis shows percent mortality from 0 to 30%. The mortality rate increases slower for Carvedilol compared to placebo, with a p-value of 0.0014 indicating statistical significance.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A forest plot showing hazard ratios with confidence intervals for various patient subgroups, including men, women, age groups, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use, compared against a reference line at hazard ratio 1.0.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph titled 'Survival Analysis for CAPRICORN (intent-to-treat)' showing percentage mortality over 24 months. It compares mortality for two groups labeled 'Placebo' and 'Carvedilol,' with Carvedilol group showing lower mortality rates. The x-axis represents time in months, and the y-axis indicates percentage mortality. A p-value of 0.03 is noted on the graph.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A figure titled 'Effects on Mortality for Subgroups in CAPRICORN' showing hazard ratio plots with confidence intervals. The chart compares multiple patient subgroups including age, gender, timing post-MI randomization, prior treatments, medical conditions, and physiological measures, displaying the hazard ratios for mortality outcomes.*
FDA Label Image

Carvedilol-chemical-structure (Structure)

Carvedilol-chemical-structure (Structure)
Chemical structure of carvedilol, the active ingredient in the product. The diagram shows its molecular formula with aromatic rings, hydroxyl, and ether functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.